Displaying all 3 publications

Abstract:
Sort:
  1. Fulltext Performance of a novel left ventricular lead with short bipolar spacing for cardiac resynchronization therapy: primary results of the Attain Performa quadripolar left ventricular lead study
    Crossley GH, Biffi M, Johnson B, Lin A, Gras D, Hussin A, et al.
    Heart Rhythm, 2015 Apr;12(4):751-8.
    PMID: 25533587 DOI: 10.1016/j.hrthm.2014.12.019
    The Medtronic Attain Performa quadripolar leads provide 16 pacing vectors with steroid on every electrode. This includes a short bipolar configuration between the middle 2 electrodes.
    Matched MeSH terms: Cardiac Resynchronization Therapy/adverse effects
  2. Novel active fixation mechanism permits precise placement of a left ventricular lead: early results from a multicenter clinical study
    Yee R, Gadler F, Hussin A, Bin Omar R, Khaykin Y, Verma A, et al.
    Heart Rhythm, 2014 Jul;11(7):1150-5.
    PMID: 24801899 DOI: 10.1016/j.hrthm.2014.04.020
    Left ventricular (LV) lead implantation for cardiac resynchronization therapy (CRT) is associated with lead dislodgement rates ranging from 3% to 10%, and some implant approaches to prevent dislodgement may contribute to suboptimal CRT response. We report our early human experience with an LV lead with a side helix for active fixation to the coronary vein wall.
    Matched MeSH terms: Cardiac Resynchronization Therapy/adverse effects
  3. Fulltext A comparison of long-term outcomes between narrow and broad QRS complex patients treated with cardiac resynchronization therapy
    Yap LB, Nguyen ST, Qadir F, Ma SK, Muhammad Z, Koh KW, et al.
    Acta Cardiol, 2016 Jun;71(3):323-30.
    PMID: 27594128 DOI: 10.2143/AC.71.3.3152093
    Matched MeSH terms: Cardiac Resynchronization Therapy/adverse effects*
Related Terms
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links